ATE476968T1 - Granulat-zubereitungen zur oralen verabreichung - Google Patents

Granulat-zubereitungen zur oralen verabreichung

Info

Publication number
ATE476968T1
ATE476968T1 AT01963438T AT01963438T ATE476968T1 AT E476968 T1 ATE476968 T1 AT E476968T1 AT 01963438 T AT01963438 T AT 01963438T AT 01963438 T AT01963438 T AT 01963438T AT E476968 T1 ATE476968 T1 AT E476968T1
Authority
AT
Austria
Prior art keywords
oral administration
taking
granule preparations
grain
feeling
Prior art date
Application number
AT01963438T
Other languages
English (en)
Inventor
Tatsuo Nomura
Original Assignee
Mitsubishi Tanabe Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Tanabe Pharma Corp filed Critical Mitsubishi Tanabe Pharma Corp
Application granted granted Critical
Publication of ATE476968T1 publication Critical patent/ATE476968T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT01963438T 2000-09-06 2001-09-05 Granulat-zubereitungen zur oralen verabreichung ATE476968T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000269526 2000-09-06
PCT/JP2001/007697 WO2002019993A1 (fr) 2000-09-06 2001-09-05 Preparations de granules pour administration orale

Publications (1)

Publication Number Publication Date
ATE476968T1 true ATE476968T1 (de) 2010-08-15

Family

ID=18756115

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01963438T ATE476968T1 (de) 2000-09-06 2001-09-05 Granulat-zubereitungen zur oralen verabreichung

Country Status (11)

Country Link
US (1) US7964218B2 (de)
EP (1) EP1323418B1 (de)
JP (1) JP3883505B2 (de)
KR (1) KR100790056B1 (de)
CN (1) CN1250205C (de)
AT (1) ATE476968T1 (de)
AU (1) AU2001284434A1 (de)
CA (1) CA2421240C (de)
DE (1) DE60142789D1 (de)
ES (1) ES2350307T3 (de)
WO (1) WO2002019993A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104258408B (zh) 2010-03-31 2017-10-03 持田制药株式会社 易服用性固体制剂
CN103813807B (zh) 2011-09-30 2017-02-08 持田制药株式会社 易服用性固体制剂
CN105476969A (zh) * 2015-12-18 2016-04-13 北京万全德众医药生物技术有限公司 考来替兰分散片及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4999189A (en) * 1988-11-14 1991-03-12 Schering Corporation Sustained release oral suspensions
DE59000232D1 (de) 1989-02-11 1992-09-10 Bayer Ag Arzneimittel mit kontrollierter wirkstoffabgabe.
IT1246382B (it) 1990-04-17 1994-11-18 Eurand Int Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon
CA2129079C (en) * 1993-08-03 2006-01-17 Tatsuo Nomura Orally administrable cholesterol lowering agent
EP0811374A1 (de) * 1996-05-29 1997-12-10 Pfizer Inc. Formulierung für ein Kombinationspräparat mit Cetirizin und Pseudoephedrin
GB9620709D0 (en) 1996-10-04 1996-11-20 Danbiosyst Uk Colonic delivery of weak acid drugs
JP4010585B2 (ja) 1996-10-15 2007-11-21 久光製薬株式会社 陰イオン交換樹脂を含有する錠剤
US6066336A (en) * 1997-09-29 2000-05-23 Bristol-Myers Squibb Company Cholesterol-lowering tablets
US6174873B1 (en) * 1998-11-04 2001-01-16 Supergen, Inc. Oral administration of adenosine analogs

Also Published As

Publication number Publication date
JP3883505B2 (ja) 2007-02-21
CA2421240A1 (en) 2003-03-05
EP1323418A1 (de) 2003-07-02
WO2002019993A1 (fr) 2002-03-14
CA2421240C (en) 2010-03-23
EP1323418A4 (de) 2007-05-30
WO2002019993A8 (fr) 2003-11-13
KR100790056B1 (ko) 2007-12-31
DE60142789D1 (de) 2010-09-23
CN1250205C (zh) 2006-04-12
AU2001284434A1 (en) 2002-03-22
JPWO2002019993A1 (ja) 2004-01-15
CN1452480A (zh) 2003-10-29
ES2350307T3 (es) 2011-01-20
US20040101567A1 (en) 2004-05-27
EP1323418B1 (de) 2010-08-11
US7964218B2 (en) 2011-06-21
KR20030036756A (ko) 2003-05-09

Similar Documents

Publication Publication Date Title
JP2008540649A5 (de)
WO2006124366A8 (en) Flavoring of drug-containing chewing gums
EP1317916A3 (de) Filme enthaltend modifizierte Stärke
CA2307018A1 (en) Osmotic medicament releasing system
SE9803772D0 (sv) Pharmaceutical formulation
WO2002072033A3 (en) Chronotherapeutic dosage forms containing glucocorticosteroid
CA2371940A1 (en) Pregelatinized starch in a controlled release formulation
BR0103033A (pt) Partìculas farmacêuticas de sabor mascarado
DK0868912T3 (da) Anvendelse af redispergerbare polymerpulvere eller polymergranulater til coating af farmaceutiske eller agrokemiske applikationsformer
CA2277017A1 (en) Rapidly releasing and taste-masking pharmaceutical dosage form
ATE396712T1 (de) Pharmazeutische zubereitung zur modifizierten freisetzung
EP1334728A3 (de) Antitrombotische Mittel
BG108516A (en) Pharmaceutical formulation
WO2002058672A3 (en) Microparticles of biodegradable polymer encapsulating a biologically active substance
AU2357202A (en) Ion-strength independent sustained release pharmaceutical formulation
MXPA03008420A (es) Forma farmaceutica solida oralmente dispersa.
EP0931545A3 (de) Droloxifen pharmazeutische Zusammenstellung
ATE476968T1 (de) Granulat-zubereitungen zur oralen verabreichung
ATE286894T1 (de) 2h-1-benzopyran-derivate, prozesse zu ihrer herstellung und pharmazeutische zusammensetzungen
HUP0202324A2 (hu) Prukaloprid orális oldat
JP2005526061A5 (de)
EP1273301A3 (de) Pharmazeutische Zubereitungen, Wirkstoffe enthaltend, die sich für unerlaubte Verabreichung bieten
WO2004096175A3 (en) Taste masked microcapsules and processes for their preparation
CA2436537A1 (en) Pharmaceutical compositions comprising tiotropium salts and antihistamines
BR0115206A (pt) Composições hidroliticamente instáveis

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties